152 related articles for article (PubMed ID: 2995494)
21. Further evidence against a role for toxic oxygen products as lytic agents in NK cell-mediated cytotoxicity.
Van Kessel KP; Van Strijp JA; Van Kats-Renaud HJ; Miltenburg LA; Van Der Tol ME; Fluit AC; Verhoef J
Immunology; 1987 Dec; 62(4):675-8. PubMed ID: 3480874
[TBL] [Abstract][Full Text] [Related]
22. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of natural killer cell-mediated cytotoxicity by lipids extracted from Mycobacterium bovis BCG.
Roozemond RC; Halperin M; Das PK
Clin Exp Immunol; 1985 Dec; 62(3):482-90. PubMed ID: 3910316
[TBL] [Abstract][Full Text] [Related]
24. Human interleukin-2-activated adherent natural killer cells recognize a conserved antigen found on tumor cells and protozoan parasites.
Weisman Z; Evans DL; Jaso-Friedmann L
Nat Immun; 1996-1997; 15(6):269-84. PubMed ID: 9523279
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of human NK cell cytotoxicity against K562 cells with glycopeptides from K562 plasma membranes.
Decker JM; Hinson A; Ades EW
J Clin Lab Immunol; 1984 Nov; 15(3):137-43. PubMed ID: 6397595
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
Steele TA; Brahmi Z
J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
[TBL] [Abstract][Full Text] [Related]
27. Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production.
Kubo M; Morisaki T; Matsumoto K; Tasaki A; Yamanaka N; Nakashima H; Kuroki H; Nakamura K; Nakamura M; Katano M
Cancer Immunol Immunother; 2005 May; 54(5):468-76. PubMed ID: 15592829
[TBL] [Abstract][Full Text] [Related]
28. PGE1 and prostacyclin suppression of NK-cell mediated cytotoxicity and its relation to cyclic AMP.
Lanefelt F; Ullberg M; Jondal M; Fredholm BB
Med Biol; 1983; 61(6):324-30. PubMed ID: 6328136
[TBL] [Abstract][Full Text] [Related]
29. Relationships of prostaglandin levels and natural killer (NK) cell cytotoxicity of mononuclear cells in cord blood.
Ching CY; Ching N; Seto DS; Hokama Y
J Med; 1984; 15(3):233-6. PubMed ID: 6597256
[TBL] [Abstract][Full Text] [Related]
30. Ethanol and natural killer cells. II. Stimulation of human natural killer activity by ethanol in vitro.
Li F; Cook RT; Alber C; Rasmussen W; Stapleton JT; Ballas ZK
Alcohol Clin Exp Res; 1997 Sep; 21(6):981-7. PubMed ID: 9309305
[TBL] [Abstract][Full Text] [Related]
31. Regulation of human natural killing. III. Mechanism for interferon induction of loss of susceptibility to suppression by cyclic AMP elevating agents.
Leung KH; Koren HS
J Immunol; 1984 Mar; 132(3):1445-50. PubMed ID: 6319493
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells.
Linnemeyer PA; Pollack SB
J Immunol; 1993 May; 150(9):3747-54. PubMed ID: 8386202
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
34. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
35. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U
J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991
[TBL] [Abstract][Full Text] [Related]
36. Tricyclic antidepressants inhibit human natural killer cells.
Xiao L; Eneroth P
Toxicol Appl Pharmacol; 1996 Apr; 137(2):157-62. PubMed ID: 8661340
[TBL] [Abstract][Full Text] [Related]
37. Activation of protein kinase C by lipoxin A and other eicosanoids. Intracellular action of oxygenation products of arachidonic acid.
Hansson A; Serhan CN; Haeggström J; Ingelman-Sundberg M; Samuelsson B
Biochem Biophys Res Commun; 1986 Feb; 134(3):1215-22. PubMed ID: 2418836
[TBL] [Abstract][Full Text] [Related]
38. Suppressive effects of pentoxifylline on natural killer cell activity.
Reed WR; DeGowin RL
J Lab Clin Med; 1992 Jun; 119(6):763-71. PubMed ID: 1593221
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of inhibition of natural killing by a glycopeptide isolated from the K562 plasma membrane.
Targan S; Decker JM; Ades EW
Nat Immun Cell Growth Regul; 1983-1984; 3(3):113-23. PubMed ID: 6438498
[TBL] [Abstract][Full Text] [Related]
40. Natural killer cell-mediated lysis involves an hydroxyl radical-dependent step.
Duwe AK; Werkmeister J; Roder JC; Lauzon R; Payne U
J Immunol; 1985 Apr; 134(4):2637-44. PubMed ID: 2982948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
